Skip to main navigation Skip to search Skip to main content

Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection

  • Brian C. Baumann
  • , Suneel N. Nagda
  • , James D. Kolker
  • , William P. Levin
  • , Kristy L. Weber
  • , Abigail T. Berman
  • , Arthur Staddon
  • , Lee Hartner
  • , Stephen M. Hahn
  • , Eli Glatstein
  • , Charles B. Simone
  • University of Pennsylvania
  • University of Texas MD Anderson Cancer Center

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Abstract

Background/Objectives: Oligometastatic sarcoma pulmonary metastases (PM) are typically treated with resection and/or chemotherapy. We hypothesize that stereotactic body radiotherapy (SBRT) can be an alternative to surgery that can achieve high rates of local control (LC) with limited toxicity. Methods: Thirty consecutive sarcoma patients received SBRT to 39 PM's from 2011 to 2015 at two university hospitals to a median dose of 50 Gy in 4–5 fractions with CyberKnife or linear accelerator. Patients underwent CT or PET/CT scans q3 months after SBRT. Results: 77% received prior chemotherapy, 70% had 1–3 prior pulmonary resections, and 26% received prior thoracic radiotherapy. Median lesion size was 2.4 cm (range 0.5–8.1 cm). Median follow-up was 16 and 23 months for patients alive at last follow-up. At 12 and 24 months, LC was 94% and 86%, and OS was 76% and 43%. LC and OS did not differ by SBRT technique, fractionation regimen, lesion location, histology, or size (all P > 0.05). Three developed grade 2 chest-wall toxicity with no other grade ≥2 toxicities. Conclusions: This is the largest series on SBRT for sarcoma PM's and demonstrates that SBRT is well-tolerated with excellent LC across tumor locations and sizes. SBRT should be considered in these patients, and prospective studies are warranted. J. Surg. Oncol. 2016;114:65–69.

Original languageEnglish
Pages (from-to)65-69
Number of pages5
JournalJournal of Surgical Oncology
Volume114
Issue number1
DOIs
StatePublished - Jul 1 2016

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents/therapeutic use
  • Chemotherapy, Adjuvant
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms/diagnostic imaging
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Positron-Emission Tomography
  • Radiosurgery
  • Radiotherapy, Adjuvant
  • Sarcoma/diagnostic imaging
  • Tomography, X-Ray Computed
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: A potential alternative to resection'. Together they form a unique fingerprint.

Cite this